Table 2.

Dominant SARS-CoV B cell epitope regions

SARS		2019 nCoV
Sequence	Max RF	Sequence	Proteina	Mapped Start-End	Identity (%)
DAVDCSQNPLAELKCSVKSFEIDKGIYQTSNF	0.504	DAVDCALDPLSETKCTLKSFTVEKGIYQTSN	S	287-317	69
VCGPKLSTDLIKNQCVNFNFNGLTGTGVLTPSSKRFQPFQQFGRDVSDFTDSVRDPKTSEILDISPCSFGGVSVIT	0.745	VCGPKKSTNLVKNKCVNFNFNGLTGTGVLTESNKKFLPFQQFGRDIADTTDAVRDPQTLEILDITPCSFGGVSVI	S	524-598	80
GTNASSEVAVLYQDVNCTDVSTAIHADQLTPAWRIYSTGNN	0.709	GTNTSNQVAVLYQDVNCTEVPVAIHADQLTPTWRVYSTGS	s	601-640	78
FSQILPDPLKPTKRSFIED	0.365	FSQILPDPSKPSKRSFIE	s	802-819	89
FGAGAALQIPFAMQMAYRFNGIG	0.367	FGAGAALQIPFAMQMAYRFNGI	s	888-909	100
MADNGTITVEELKQLLEQWNLVIG	0.460	MADSNGTITVEELKKLLEQWNLVI	M	1-24	92
PLMESELVIGAVIIRGHLRMA	0.457	PLLESELVIGAVILRGHLRI	M	132-151	90
PQGLPNNTASWFTALTQHGKEE	0.537	RPQGLPNNTASWFTALTQHGK	N	42-62	95
NNAATVLQLPQGTTLPKGFYA	0.543	NNNAATVLQLPQGTTLPKGF	N	153-172	95
KHIDAYKTFPPTEPKKDKKKKTDEAQPLPQRQKKQPTVTLLPAADMDD	0.82	NKHIDAYKTFPPTEPKKDKKKKTDEAQPLPQRQKKQPTVTLLPAADM	N	355-401	90

^a.S= surface glycoprotein; M=membrane protein; N=nucleocapsid phosphoprotein